Anzeige
Mehr »
Montag, 16.02.2026 - Börsentäglich über 12.000 News
FRIEDLANDS 10.000-JAHRE-SCHOCK: Der Kupfer-Engpass hat begonnen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
366 Leser
Artikel bewerten:
(2)

Psoriatic Disease To Take Center Stage at the UN General Assembly: IFPA Calls for Greater Recognition of Psoriatic Disease During UN High-Level Meetings

STOCKHOLM, Sept. 11, 2025 /PRNewswire/ -- The International Federation of Psoriasis Associations (IFPA) spotlights psoriatic disease at the upcoming UNGA 80 in New York, where world leaders are expected to adopt a new Political Declaration on noncommunicable diseases (NCDs), mental health and well-being.

Frida Dunger - Executive Director of IFPA credit: IFPA

Key Highlights:

  • An estimated 60 million people worldwide are affected by psoriatic disease - a serious, lifelong noncommunicable disease that impacts the skin, joints, and other organs. Psoriasis also increases risks for diabetes, obesity, cardiovascular disease and depression.
  • Despite a 2014 World Health Organization (WHO) resolution recognizing psoriasis as a major public health concern, progress has been slow, prompting IFPA (International Federation of Psoriasis Associations) to call for renewed global commitment.
  • IFPA representatives are traveling to the UN High-Level Meeting on NCDs to advocate for the inclusion of people with psoriatic disease in global and national health policies, with a special focus on putting lived experience at the heart of policymaking.

Read more about this event and register: https://pages.devex.com/devex-at-unga-80

Psoriatic disease is a lifelong, systemic inflammatory condition, often coexisting with other NCDs, such as diabetes, obesity, cardiovascular diseases and depression. An estimated 60 million people live with the disease. Despite the numbers, psoriatic disease has been overlooked in the health systems worldwide.

The first and only resolution on psoriasis was adopted by WHO in 2014, recognizing it as a major public health concern. Since then, the progress has been poor. IFPA is calling for a greater global commitment to ensure that the needs of people with psoriatic disease are integrated into global and national health policies.

To amplify this call, IFPA representatives are traveling to New York to participate in the upcoming United Nations High-Level Meeting on Noncommunicable Diseases (NCDs) - at UN Headquarters on September 25. This event brings together health leaders, experts, and policymakers to shape the future of NCD prevention and care. IFPA is seizing this opportunity to advocate for more inclusive policies, improved access to care, and greater recognition of psoriatic disease within the broader NCD agenda.

As a part of this advocacy initiative, IFPA organizes a high-level conversation in partnership with Devex on the sidelines of UNGA, titled: Psoriatic Disease and NCDs: Putting Lived Experience at the Heart of Policy. The event takes place at the Devex NCD Pavilion in New York on September, 22.

More details about this advocacy event and registration: https://pages.devex.com/devex-at-unga-80

The session will feature Frida Dunger, Executive Director of IFPA, and Kate Reynolds, IFPA ambassador, living with psoriatic disease. The speakers will share powerful perspectives on why lived experience must move to the center of global health policymaking.

"People living with psoriatic disease are more than our illness, we are whole people, and we need to live our best lives, just like anybody else. I am traveling to New York to speak up about psoriasis at this event because, in my opinion, there should be no decisions about us without us, - shares Kate Reynolds, IFPA Ambassador.

"Inclusive health policy is not optional, it is essential for ensuring that over 60 million people across the globe, living with psoriatic disease, are no longer left behind, says Frida Dunger, Executive Director of IFPA.

About IFPA

IFPA (the International Federation of Psoriasis Associations), founded in 1971 and based in Stockholm, Sweden, is the global organization dedicated to advocating for everyone affected by psoriatic disease. IFPA's members include national and regional patient associations and represent over 60 million people worldwide. Through global coalitions, World Psoriasis Day campaigns, the IFPA Forum, and the World Psoriasis & Psoriatic Arthritis Conference, IFPA is redefining psoriatic disease as a key lens for stronger, more inclusive health systems. Learn more: https://www.ifpa-pso.com/

Photo - https://mma.prnewswire.com/media/2771187/Frida_Dunger.jpg
Photo - https://mma.prnewswire.com/media/2771188/United_Nations_Headquarters_New_York.jpg
Logo - https://mma.prnewswire.com/media/2771186/IFPA_Logo.jpg

United Nations Headquarters in New York Credit: UN

IFPA - International Federation of Psoriasis Associations

Cision View original content:https://www.prnewswire.co.uk/news-releases/psoriatic-disease-to-take-center-stage-at-the-un-general-assembly-ifpa-calls-for-greater-recognition-of-psoriatic-disease-during-un-high-level-meetings-302554184.html

© 2025 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.